• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Neutralizing Antibodies to SARS-CoV-2 Persist for at Least 5 Months

Since December 2019, SARS-CoV-2 has infected over 46 million individuals worldwide leading to over 1 million deaths.  While the majority…

November 3, 2020

Cochrane Living Systematic Review: More Data Needed to Determine Efficacy of COVID-19 Convalescent Plasma

Researchers from the Cochrane Library are performing monthly systematic reviews to evaluate the current data on the effectiveness of COVID-19…

October 28, 2020

No Evidence of SARS-CoV-2 Transfusion Transmission or Viral Infectivity

About 20-25% of individuals infected with SARS-CoV-2 develop severe symptoms, but many infected individuals are asymptomatic and may donate blood…

October 21, 2020

Meta-Analysis Examines Leukapheresis in Patients with Acute Myeloid Leukemia and Hyperleukocytosis

Hyperleukocytosis (a white blood cell count greater than 100 X 109/L) is a medical emergency with a mortality rate up…

October 14, 2020

Serosurveillance of SARS-CoV-2 from Blood Donations across the U.S.

The RESPONSE (REDS-IV-P Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 Epidemic) Study aims to screen blood donations and monitor…

October 7, 2020

COVID-19 Pandemic Impacts Blood Donation Trends

In order to assess the effect of the COVID-19 pandemic on blood donations, researchers at OneBlood in Florida reviewed 264,593…

October 7, 2020

COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies

With few drugs to combat SARS-CoV-2 infections and the approval from the U.S. FDA for Emergency Use Authorization of COVID-19…

September 30, 2020

Less than 2% of U.S. Blood Donations Positive for SARS-CoV-2 Antibodies

In order to gain a better understanding of SARS-CoV-2 seroprevalence, the American Red Cross tested all blood donations from June…

September 22, 2020

Minimal Concerns for HIV in the US Blood Supply after FDA Revised Guidance

In 2015, the U.S. FDA revised guidance for blood donor deferral of men who have sex with men (MSM) from…

September 15, 2020

NIH Urges Randomized Controlled Trials for COVID-19 Convalescent Plasma

On September 1, 2020, shortly after the U.S. Food and Drug’s Emergency Use Authorization (EUA) for the use of COVID-19…

September 9, 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Latest News

  • RBCs with Reduced Deformability are Removed from Circulation

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley